Aegis Therapeutics LLC-製薬・医療分野:企業M&A・提携分析

◆英語タイトル:Aegis Therapeutics LLC - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA8011813
◆発行会社(調査会社):GlobalData
◆発行日:2017年12月13日
◆ページ数:19
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥27,250見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥54,500見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥81,750見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Aegis Therapeutics LLC (Aegis Therapeutics) is a biotechnology company that research and develops drug delivery and drug formulation technologies. The company commercializes new drug delivery and protein stabilization technologies through product specific licenses to pharmaceutical and biopharmaceutical companies. It provides a drug delivery technology that allows the non invasive delivery of a broad range of protein, peptide, nucleotide, non peptide and other small and large molecule drugs. Aegis Therapeutics also provides protein stabilization technology, which creates homogeneous, stable, aqueous or lyophilized dosage forms for peptide or protein therapeutics. Aegis Therapeutics is headquartered in San Diego, California, the US.

Aegis Therapeutics LLC – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Aegis Therapeutics LLC, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Aegis Therapeutics LLC, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Aegis Therapeutics LLC, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Aegis Therapeutics LLC, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 8
Aegis Therapeutics LLC, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 9
Aegis Therapeutics LLC, Pharmaceuticals & Healthcare, Deal Details 10
Partnerships 10
Aegis Therapeutics Enters into Co-Development Agreement with Albany Medical College 10
Licensing Agreements 12
Opiant Pharma Enters into Licensing Agreement with Aegis Therapeutics 12
Dauntless Pharma Enters into Licensing Agreement with Aegis Therapeutics 14
Biodel Enters Into Licensing Agreement With Aegis Therapeutics For ProTek And Intravail Technologies 15
Aegis Therapeutics LLC – Key Competitors 16
Aegis Therapeutics LLC – Key Employees 17
Aegis Therapeutics LLC – Locations And Subsidiaries 18
Head Office 18
Appendix 19
Methodology 19
About GlobalData 19
Contact Us 19
Disclaimer 19

List of Tables
Aegis Therapeutics LLC, Pharmaceuticals & Healthcare, Key Facts 2
Aegis Therapeutics LLC, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Aegis Therapeutics LLC, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Aegis Therapeutics LLC, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Aegis Therapeutics LLC, Deals By Therapy Area, 2011 to YTD 2017 8
Aegis Therapeutics LLC, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 9
Aegis Therapeutics Enters into Co-Development Agreement with Albany Medical College 10
Opiant Pharma Enters into Licensing Agreement with Aegis Therapeutics 12
Dauntless Pharma Enters into Licensing Agreement with Aegis Therapeutics 14
Biodel Enters Into Licensing Agreement With Aegis Therapeutics For ProTek And Intravail Technologies 15
Aegis Therapeutics LLC, Key Competitors 16
Aegis Therapeutics LLC, Key Employees 17

★海外企業調査レポート[Aegis Therapeutics LLC-製薬・医療分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • PharmaCyte Biotech, Inc. (PMCB):企業のM&A・提携動向(医療機器分野)
    Summary PharmaCyte Biotech, Inc. (PharmaCyte), formerly, Nuvilex, Inc. is a clinical stage biotechnology company that develops and commercializes treatments for cancer and diabetes. The company develops cellulose-based live cell encapsulation technology known as Cell-in-a-Box. Its technology is used …
  • Helix BioPharma Corp (HBP):企業財務及び戦略的SWOT分析
    Helix BioPharma Corp (HBP) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesse …
  • Canadian Overseas Petroleum Limited (XOP):企業の財務及び戦略的SWOT分析
    Summary Canadian Overseas Petroleum Limited (COPL) formerly Velo Energy Inc. is a mineral exploration company that provides oil and gas exploration. The company’s products include crude oil and natural gas properties. Its projects include block LB-13 and PEP 53806 in New Zealand. COPL’s projects pro …
  • Sigma Designs, Inc. (SIGM):企業財務及び戦略的SWOT分析
    Summary Sigma Designs, Inc. (Sigma Designs) is a technology company that designs system software, and technical documentation for a variety of set-top boxes, media connectivity devices, smart TVs, and internet of things devices. The company offers products, which include media processors, smart TV S …
  • NorthWestern Corporation (NWE):企業のM&A・提携動向(石油・ガス分野)
    Summary NorthWestern Corporation (NorthWestern) is an integrated electric utility that generates and distributes electricity and distributes natural gas. The company carries out business activities under the trade name of NorthWestern Energy. The company generates transmits and distributes electrici …
  • Axxam SpA(製薬・医療分野):企業M&A動向
    Summary Axxam SpA (Axxam) is a contract research and discovery service provider. The company offers discovery services such as molecular biology, assay development and reagent provision, compound management, hit characterization and profiling and electrophysiology, among others. It has developed pro …
  • Sidney Kimmel Comprehensive Cancer Center-製薬・医療分野:企業M&A・提携分析
    Summary Sidney Kimmel Comprehensive Cancer Center (Sidney Kimmel) is a healthcare service provider that concentrates on diagnosis, treatment, and prevention of cancer. The center’s specialties include cancer diagnostic and treatment planning, blood and bone marrow cancers, cancer immunotherapy, brai …
  • Aushon BioSystems Inc-医療機器分野:企業M&A・提携分析
    Summary Aushon BioSystems Inc (Aushon) is a medical device provider that offers biomarker measurement and analysis products. The company provides biomarker therapeutic areas in microarray printing technology. Its products include ciraplex assay, cirascan imaging and cirasoft analysis and cira servic …
  • Bangkok Bank Public Company Limited:企業の戦略・SWOT・財務分析
    SummaryBangkok Bank Public Company Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the …
  • Swick Mining Services, Ltd.:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' Swick Mining Services, Ltd. Mer …
  • Adimmune Corp (4142):企業のM&A・提携動向(医療分野)
    Summary Adimmune Corp (Adimmune) is a pharmaceutical company that manufactures vaccines, diagnostics, and biological products for various diseases. The company offers products such as Japan encephalitis vaccine, tetanus toxoid adsorbed vaccine, influenza vaccine, and ah1n1 vaccine. It also offers en …
  • Quanta Computer Inc. (2382):企業の財務及び戦略的SWOT分析
    Summary Quanta Computer Inc. (Quanta) is a computer hardware company. It is one of the leading notebook computer original design manufacturers (ODM) across the world. The company designs, develops and produces notebook computers, personal computers, all-in-one computers, servers, web camera and clou …
  • Finbar Group Ltd (FRI):企業の財務・戦略的SWOT分析
    Finbar Group Ltd (FRI) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses an …
  • Shandong Sacred Sun Power Sources Co.,Ltd. (002580):企業概要、財務及び戦略的SWOT分析
    Summary Shandong Sacred Sun Power Sources Co.,Ltd. (Sacred Sun) is an electrical equipment company. The company designs, develops and produces power storage solutions. It offers lead-acid batteries and lithium batteries. Sacred Sun’s products include FMJ, FT, FTJ, GFMU-C, GFM-C, GFMG, GFM-H, GFMJ, S …
  • Shougang Fushan Resources Group Limited.:企業概要・SWOT分析
    This report is a crucial resource for industry executives and anyone looking to access key information about "Shougang Fushan Resources Group Limited." The report utilizes a wide range of primary and secondary sources, which are analyzed and presented in a consistent and easily accessible format. Ti …
  • ULURU Inc. (ULUR):企業概要、財務及び戦略的SWOT分析
    Summary Uluru Inc. (Uluru) is a pharmaceutical company. The company develops and commercializes wound care and muco-adhesive film products. It offers products under various brand names such as Altrazeal, Apthasol, OraDisc A, OraDisc B, and OraDisc W. Uluru’s Altrazeal is a transforming powder dressi …
  • Gene Network Sciences, Inc.:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' Gene Network Sciences, Inc. Mer …
  • Diploma PLC (DPLM):企業財務及び戦略的SWOT分析
    Summary Diploma PLC (Diploma) is a business organization that offers technical products and services. The organization conducts business through the segments such as life sciences, seals and controls. Its life sciences segment supplies consumables, instrumentation and related services to the healthc …
  • Perilya Limited:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' Perilya Limited Mergers and Acq …
  • Orlando Utilities Commission:企業の戦略的SWOT分析
    Orlando Utilities Commission - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major produc …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆